FOLFOX Induced Takotsubo Cardiomyopathy Treated with Impella Assist Device. (7th March 2017)

• Record Type: Journal Article
• Authors: Sundaravel, Swethika; Alrifai, Abdulah; Kabach, Mohamad; Ghumman, Waqas
• Other Names: Ferrari Markus Academic Editor.
• Is Part Of: Case reports in cardiology. Volume 2017(2017)
• Publication Date: 2017-03-07
• Subjects: Cardiology -- Periodicals; 616.12005
• DOI: 10.1155/2017/8507096
• Languages: English
• ISSNs: 2090-6404

Abstract

Abstract : Chemotherapy induced cardiotoxicity is becoming increasingly prevalent with several new agents being used recently. The incidence of Takotsubo cardiomyopathy due to 5-fluorouracil based chemotherapeutic regimens like FOLFOX is not uncommon. It is also seen with platinum based chemotherapy. Most of these patients have reversible cardiotoxicity and the cardiac function recovers within a short period with supportive treatment. Here we have a patient who presented with cardiogenic shock after 5 days of receiving FOLFOX regimen for colorectal adenocarcinoma. She was treated with a percutaneous left ventricular assist device, Impella CP, for hemodynamic support with excellent outcome.